Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
McKinsey
Novartis
UBS
Chubb
Teva
Covington
Argus Health
Harvard Business School
Johnson and Johnson

Generated: January 18, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 040159

« Back to Dashboard

NDA 040159 describes MEDROXYPROGESTERONE ACETATE, which is a drug marketed by Sandoz Inc, Teva Pharms Usa, Barr, Duramed Pharms Barr, and Usl Pharma, and is included in six NDAs. It is available from seventeen suppliers. Additional details are available on the MEDROXYPROGESTERONE ACETATE profile page.

The generic ingredient in MEDROXYPROGESTERONE ACETATE is medroxyprogesterone acetate. There are nineteen drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the medroxyprogesterone acetate profile page.
Summary for 040159
Pharmacology for NDA: 040159
Ingredient-typeProgesterone Congeners
Suppliers and Packaging for NDA: 040159
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
MEDROXYPROGESTERONE ACETATE medroxyprogesterone acetate TABLET;ORAL 040159 ANDA Teva Pharmaceuticals USA, Inc. 0555-0779 0555-0779-04 500 TABLET in 1 BOTTLE (0555-0779-04)
MEDROXYPROGESTERONE ACETATE medroxyprogesterone acetate TABLET;ORAL 040159 ANDA Teva Pharmaceuticals USA, Inc. 0555-0779 0555-0779-02 100 TABLET in 1 BOTTLE (0555-0779-02)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength2.5MG
Approval Date:Aug 9, 1996TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength5MG
Approval Date:Aug 9, 1996TE:ABRLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength10MG
Approval Date:Aug 9, 1996TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Federal Trade Commission
McKinsey
Cipla
US Department of Justice
Queensland Health
Julphar
Boehringer Ingelheim
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot